The test requires a doctor’s authorization and a venous blood draw. Please select one of the following options:
For most cancers, early detection can save lives. OneTest™ is one of the most affordable tool to help detect cancers early.
Recent studies have demonstrated that genetics only accounts for around 5% of cancers.
Those concerned about their risk of cancer, even with little or no family history may benefit from routine cancer marker testing. This approach has become standard practice in Japan, Korea, China and throughout East Asia where nearly all adults receive checkups that include many of the biomarkers in OneTest™.
We measure tumor proteins not genes. Popular DNA tests look for inherited genes that pre-dispose one to various diseases. Such tests have limited value for early cancer detection since recent studies have confirmed that fewer than 5% of the genetic mutations that cause cancer are inherited. Instead, most cancer-causing mutations result from random DNA copying errors over time.
OneTest™ is among the first multi-cancer screening panels to harness the power of AI to improve the accuracy of tumor marker tests to help identify 20+ types of cancer.
Based around a panel of tumor markers such as PSA, CEA, AFP, CA-125 and others, OneTest™ can aid in the early detection of many types of cancer, including those not commonly screened for such as lung, liver, pancreas, etc. OneTest™ is powered by real-world, cancer-screening results from tens of thousands of people.